MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$10.65 +0.33 (+3.20%)
At close: Oct 21, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Treasury Shares (2021 - 2022)

Updated

MoonLake Immunotherapeutics (MLTX) posted Treasury Shares of $6,202 for Q4 2021.

Analysis

MoonLake Immunotherapeutics (MLTX) Treasury Shares (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 711.62 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 77.11 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.11 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 3.94 Bn
10 MoonLake Immunotherapeutics 783.87 Mn -885.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 765,483.00
Dec 31, 2021 1.94 Mn
API Access

MoonLake Immunotherapeutics Treasury Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=MLTX&period=max&api_key=YOUR_API_KEY